Evidence map›Paper›PMID 30504831›Full record

ArticleNature communications2018

Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle.

John T Olthoff, Angus Lindsay, Reem Abo-Zahrah, Kristen A Baltgalvis, Xiaobai Patrinostro, Joseph J Belanto, Dae-Yeul Yu, Benjamin J Perrin, Daniel J Garry, George G Rodney and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Twisting Paths: The Paradox of Fiber Branching in Muscle Regeneration.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Lifespan Analysis of DystrophicFrontiers in physiology · 2021
    Article
  18. Review
  19. Cancer cachexia in a mouse model of oxidative stress.Journal of cachexia, sarcopenia and muscle · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

John T OlthoffMolecular, Cellular, Developmental Biology, and Genetics Graduate Program, University of Minnesota, Minneapolis, MN, 55455, USA.
Angus LindsayDivisions of Rehabilitation Science and Physical Therapy, Department of Rehabilitation Medicine, University of Minnesota, Minneapolis, MN, 55455, USA.
Reem Abo-ZahrahDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, 77030, USA.
Kristen A BaltgalvisDivisions of Rehabilitation Science and Physical Therapy, Department of Rehabilitation Medicine, University of Minnesota, Minneapolis, MN, 55455, USA.
Xiaobai PatrinostroDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, 55455, USA.
Joseph J BelantoDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, 55455, USA.
Dae-Yeul YuAging Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
Benjamin J PerrinDepartment of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46022, USA.
Daniel J GarryLillehei Heart Institute and Department of Medicine, University of Minnesota, Minneapolis, MN, 55455, USA.
George G RodneyDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, 77030, USA.
Dawn A LoweDivisions of Rehabilitation Science and Physical Therapy, Department of Rehabilitation Medicine, University of Minnesota, Minneapolis, MN, 55455, USA.
James M ErvastiMolecular, Cellular, Developmental Biology, and Genetics Graduate Program, University of Minnesota, Minneapolis, MN, 55455, USA. jervasti@umn.edu.
University of Minnesota · USBaylor College of Medicine · USIndiana University – Purdue University Indianapolis · USKorea Research Institute of Bioscience and Biotechnology · KRMinneapolis Heart Institute Foundation · US

Funding

TRAINING PROGRAM IN MUSCLE RESEARCHT32AR007612 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JAMES M ERVASTI, DAWN A LOWE · 2001 to 2026
$11.3M
Costamere Defects in Muscular DystrophiesR01AR049899 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI ERVASTI, JAMES M · 2005 to 2025
$8.2M
Training Grant: Functional Proteomics of AgingT32AG029796 · NIA · UNIVERSITY OF MINNESOTA · PI EDGAR A ARRIAGA, Douglas G Mashek · 2008 to 2026
$6.6M
Nox2-Calcium Signaling in Skeletal MuscleR01AR061370 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI RODNEY, GEORGE G · 2012 to 2021
$4.1M
Use of specific transcription factors to promote limb regeneration capacityP30AR057220 · NIAMS · UNIVERSITY OF MINNESOTA · PI ERVASTI, JAMES M · 2009 to 2013
$3.0M
NIAMS NIH HHS P30 AR057220NIAMS NIH HHS R01 AR049899NIAMS NIH HHS R01 AR061370NIAMS NIH HHS T32 AR007612NIA NIH HHS T32 AG029796
6 · The paper itself

Abstract

Force loss in skeletal muscle exposed to eccentric contraction is often attributed to injury. We show that EDL muscles from dystrophin-deficient mdx mice recover 65% of lost force within 120 min of eccentric contraction and exhibit minimal force loss when the interval between contractions is increased from 3 to 30 min. A proteomic screen of mdx muscle identified an 80% reduction in the antioxidant peroxiredoxin-2, likely due to proteolytic degradation following hyperoxidation by NADPH Oxidase 2. Eccentric contraction-induced force loss in mdx muscle was exacerbated by peroxiredoxin-2 ablation, and improved by peroxiredoxin-2 overexpression or myoglobin knockout. Finally, overexpression of γ

Indexed as

AnimalsDystrophinImmunoblottingImmunoprecipitationMaleMiceMice, Inbred C57BLMuscle ContractionMuscle, SkeletalPeroxiredoxinsDystrophinPeroxiredoxins

Identifiers

PMID30504831
PMCPMC6269445
OpenAlexW2903339831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.